Gene · 186
Papers1,962
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,962
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| System Analysis Based on Lipid-Metabolism-Related Genes Identifies AGT as a Novel Therapy Target for Gastric Cancer with Neoadjuvant Chemotherapy. | Pharmaceutics | 2023 | 36986671 | PubTator, text mining | PubMed |
| Vitamin D, Cellular Senescence and Chronic Kidney Diseases: What Is Missing in the Equation? | Nutrients | 2023 | 36986078 | PubTator, text mining | PubMed |
| Molecular and Epigenetic Control of Aldosterone Synthase, CYP11B2 and 11-Hydroxylase, CYP11B1. | Int J Mol Sci | 2023 | 36982850 | PubTator, text mining | PubMed |
| COVID-19-Induced Myocarditis: Pathophysiological Roles of ACE2 and Toll-like Receptors. | Int J Mol Sci | 2023 | 36982447 | PubTator, text mining | PubMed |
| Editorial: Termination of pro-inflammatory signaling and its dysregulation in autoimmune diseases. | Front Immunol | 2023 | 36969258 | PubTator, text mining | PubMed |
| Who Modifies the Modifiers: A High-Resolution View of the Genetic Modifiers of Cystic Fibrosis. | Am J Respir Crit Care Med | 2023 | 36961916 | PubTator, text mining | PubMed |
| Factors correlated with pain after total knee arthroplasty: A systematic review and meta-analysis. | PLoS One | 2023 | 36961863 | PubTator, text mining | PubMed |
| The classical and alternative circulating renin-angiotensin system in normal dogs and dogs with stage B1 and B2 myxomatous mitral valve disease. | J Vet Intern Med | 2023 | 36951394 | PubTator, text mining | PubMed |
| Neuroprotective effect of angiotensin II receptor blockers on the risk of incident Alzheimer's disease: A nationwide population-based cohort study. | Front Aging Neurosci | 2023 | 36949774 | PubTator, text mining | PubMed |
| Concise review: Current understanding of extracellular vesicles to treat neuropathic pain. | Front Aging Neurosci | 2023 | 36936505 | PubTator, text mining | PubMed |
| Metabolic pathways of potential miRNA biomarkers derived from liquid biopsy in epithelial ovarian cancer. | Oncol Lett | 2023 | 36909377 | PubTator, text mining | PubMed |
| A role for misaligned gene expression of fetal gene program in the loss of female-specific cardiovascular protection in young obese and diabetic females. | Front Endocrinol (Lausanne) | 2023 | 36909327 | PubTator, text mining | PubMed |
| Role of the renin-angiotensin system in the pathophysiology of coronary heart disease and heart failure: Diagnostic biomarkers and therapy with drugs and natural products. | Front Physiol | 2023 | 36909245 | PubTator, text mining | PubMed |
| Overcoming Acquired Drug Resistance to Cancer Therapies through Targeted STAT3 Inhibition. | Int J Mol Sci | 2023 | 36902166 | PubTator, text mining | PubMed |
| Molecular Mechanisms and Therapeutic Implications of Endothelial Dysfunction in Patients with Heart Failure. | Int J Mol Sci | 2023 | 36901752 | PubTator, text mining | PubMed |
| Mitochondrial Dysfunction in Cardiac Arrhythmias. | Cells | 2023 | 36899814 | PubTator, text mining | PubMed |
| Systematic investigation of the underlying mechanisms of GLP-1 receptor agonists to prevent myocardial infarction in patients with type 2 diabetes mellitus using network pharmacology. | Front Pharmacol | 2023 | 36865917 | PubTator, text mining | PubMed |
| The differential placental expression of ERp44 and pre-eclampsia; association with placental zinc, the ERAP1 and the renin-angiotensin-system. | Placenta | 2023 | 36848863 | PubTator, text mining | PubMed |
| Exploring the repurposing potential of telmisartan drug in breast cancer: an in-silico and in-vitro approach. | Anticancer Drugs | 2023 | 36847075 | PubTator, text mining | PubMed |
| Dexmedetomidine ameliorates ischemia-induced nerve injury by up-regulating Sox11 expression. | Ann Transl Med | 2023 | 36846013 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/186/papers?page=10